STAT
DECEMBER 18, 2023
Since states started rolling back pandemic-inspired flexibilities that allowed physicians to easily practice telehealth across state lines, virtual health care providers have criticized state-based medical licensure rules as unnecessarily burdensome, expensive, and detrimental to patient care. Now, two of them are arguing in a lawsuit that they can also be unconstitutional.
PharmaVoice
DECEMBER 18, 2023
Advancements in cloud and AI technology will transform clinical trial efficiency and engagement.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
DECEMBER 18, 2023
When faced with a loved one’s progressive neurodegenerative disease, like Alzheimer’s, or your child’s rare respiratory disease, you question why researchers and resource-backed pharma cannot bring a drug to market quickly enough to help your loved ones. Many people faced with this horror get involved to fight for better treatments.
ALiEM - Pharm Pearls
DECEMBER 18, 2023
A 19-year-old female with a past medical history of epilepsy presented to the emergency department for evaluation of rash and fever. Two days prior to presentation she began to experience fevers with a Tmax of 103°F. One day before presentation she developed a rash that began on her face and slowly spread down her body, now involving her palms. The patient endorsed associated pruritus and cervical lymphadenopathy with the rash.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
DECEMBER 18, 2023
The Department of Justice has asked a federal judge to dismiss a lawsuit brought by Humana, which alleged the government’s new audits of Medicare Advantage plans are unlawful. And if the lawsuit isn’t thrown out, the DOJ said in a new legal filing, at a minimum, it should be moved to a different federal court in Texas — away from a judge that has a track record of striking down federal health care laws.
PharmaVoice
DECEMBER 18, 2023
Dr. Mayukh Sukhatme, president and chief investment officer for Roivant, discusses the long game of partnering and business deals in biopharma.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
PharmaVoice
DECEMBER 18, 2023
A recent FDA clearance could pave the way to pin-prick blood tests at local pharmacies and potentially one day, clinical trials.
STAT
DECEMBER 18, 2023
As more data emerges that obesity drugs like Wegovy can reduce complications from heart and kidney problems as well, scientists have been wondering whether these benefits are driven by weight loss alone or also by other mechanisms. A new study suggests that one possible contributor is the drugs’ ability to reduce inflammation independent of weight loss.
pharmaphorum
DECEMBER 18, 2023
To effectively combat rare diseases, it is essential to prioritise the collection and analysis of data. This article explores how pharmaceutical companies are leveraging AI and focusing on orphan drugs to tackle rare diseases.
STAT
DECEMBER 18, 2023
It’s that time of the year again when I recognize the Best Biopharma CEO of the year. This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lilly is the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmExec
DECEMBER 18, 2023
In the coming year, efficiency and automation will take center stage to maximize constrained resources but balancing sensible financial management with strategic investments will be vital.
STAT
DECEMBER 18, 2023
Structure Therapeutics said Monday that its experimental GLP-1 pill demonstrated a 1% lowering of blood glucose and slightly more than 3% weight loss relative to a placebo in a 12-week study involving participants with type 2 diabetes — results that are preliminary but don’t quite match a competing oral drug under development by Eli Lilly.
Pharma Times
DECEMBER 18, 2023
MCI patients had 25% lower levels of serotonin compared to healthy patients Researchers from Johns Hopkins Medicine have suggested that serotonin loss in parts of the brain may play a role in cognitive decline in the early stages of Alzheimer’s disease (AD). Published in the Journal of Alzheimer’s Disease , the study was supported by other contributing scientists from the Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health.
STAT
DECEMBER 18, 2023
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. Since the development of Gleevec two decades ago, precision cancer medicines have become a driving force in biotech and a source of hope for cancer patients.
The Pharmacist
DECEMBER 18, 2023
Pharmacy contract reform is needed to ‘free up’ integration of primary and community care, a House of Lords select committee has been told. In a new report, the Integration of Primary and Community Care Committee has published evidence from various care professionals and academics in an inquiry into the obstacles to providing joined-up healthcare services. […] The post Pharmacy contract reform could help integrate care, Lords report finds appeared first on The Pharmacist.
STAT
DECEMBER 18, 2023
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we see a small biotech on the verge of ending a rare-disease program thanks to FDA difficulties — and how that impacts patients. We fete the best of this year’s biopharma CEOs (hint: GLP-1s), and talk about post-doc and patient advocacy reform.
Drug Patent Watch
DECEMBER 18, 2023
Annual Drug Patent Expirations for VENTOLIN+HFA Ventolin Hfa is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from nine suppliers. There are two patents… The post New patent expiration for Glaxosmithkline drug VENTOLIN HFA appeared first on DrugPatentWatch - Make Better Decisions.
STAT
DECEMBER 18, 2023
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that familiar routine of online meetings and deadlines has predictably returned. But you knew this would happen, yes? To cope, we are firing up the coffee kettle and brewing another cup of stimulation. Our choice today is caramel brûlée.
Pharma Times
DECEMBER 18, 2023
MCI patients had 25% lower levels of serotonin compared to healthy patients - News - PharmaTimes
STAT
DECEMBER 18, 2023
Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here. Good morning folks, we’re almost there! The shortest day of the year is this week. It’s also our last week of Morning Rounds before a break for the holidays, and the last Monday from me for 2023. See you next year!
Pharma Times
DECEMBER 18, 2023
Earlier diagnosis could increase patient survival rates by five years or more - News - PharmaTimes
pharmaphorum
DECEMBER 18, 2023
Biogen’s Skyclarys is on course to becoming the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU after it was recommended by the EMA’s human medicines committee.
Express Pharma
DECEMBER 18, 2023
Leaders of the whole pharma value chain meet at Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) to find new connections and discuss trends of the industry. The Congress is held on April, 22-23, 2024 in Amsterdam, the Netherlands Pharmaceutical Manufacturing and Packaging Congress (PHARMAP) is an annual networking event, which has a closed-door format: there are no marketing presentations and only decision-makers, technical, supply chain and procurement specialists of key companies
The Pharmacist
DECEMBER 18, 2023
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the use of fezolinetant – manufactured under the brand name of Veoza – to treat hot flushes and night sweats associated with the menopause. Julian Beach, interim executive director of healthcare quality and access at the MHRA, said the organisation was pleased to approve the […] The post Menopause drug to treat hot flushes and night sweats gets MHRA approval appeared first on The Pharmacist.
Express Pharma
DECEMBER 18, 2023
Manoj Saxena will move out of his present role to take on the role of CDH for Bayer’s Pharmaceuticals Division and Senior Bayer Representative, Bayer Group for the Australia & New Zealand (ANZ) cluster, with effect from the same date Bayer has announced that Shweta Rai will take over as Managing Director of Bayer Zydus Pharma and Country Division Head (CDH) for Bayer’s Pharmaceuticals Business in South Asia effective, January 1, 2024.
European Pharmaceutical Review
DECEMBER 18, 2023
The Novo Nordisk Foundation has committed up to DKK 1.8 billion ($260 million) to establish a state-of-the-art research and vaccine development initiative in Denmark. Developed in partnership with the University of Copenhagen and Denmark’s Statens Serum Institut , the Foundation says this the first vaccines initiative globally to focus solely on understanding how to generate immunity in the airway itself.
Express Pharma
DECEMBER 18, 2023
Capsule facility in Pithampur, Madhya Pradesh demonstrates excellence in technology enabled operations that transform value chains ACG, the world’s largest integrated supplier and service provider to pharma industry celebrated the inclusion of its capsule manufacturing facility in Pithampur, India, into the esteemed Global Lighthouse Network (GLN) by the World Economic Forum.
PharmExec
DECEMBER 18, 2023
Drug companies face new hurdles in a rapidly changing marketplace. How do they finance new drug development amid the uncertainty?
Express Pharma
DECEMBER 18, 2023
ZYIL1 is a novel oral small molecule NLRP3 inhibitor. Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation Zydus Lifesciences has announced that it has received permission from USFDA, to initiate the phase II clinical study of NLRP3 inhibitor “ZYIL1” in patients with Parkinson’s disease.
Pharmaceutical Technology
DECEMBER 18, 2023
Following US and UK approvals, the EMA’s CHMP has recommended conditional approval for Casgevy, with a decision expected in Q1 2024.
Express Pharma
DECEMBER 18, 2023
Over 10 emerging markets along with Japan, Australia and New Zealand have transitioned in this final phase of the integration of the biosimilars business acquired from Viatris Biocon Biologics has successfully completed the transition of its acquired biosimilars business in ~120 countries across advanced and emerging markets, a year ahead of schedule.
pharmaphorum
DECEMBER 18, 2023
Eisai files for approval in Japan for FGFR inhibitor tasurgratinib as a treatment for biliary tract cancers with FGFR2 gene fusions
Express Pharma
DECEMBER 18, 2023
Investors can bid for a minimum of 33 equity shares and in multiples of 33 equity shares thereafter Innova Captab has fixed the price band at Rs 426 to Rs 448 per equity share for its maiden Initial Public Offer (IPO). The IPO of the company will open on Thursday, December 21, 2023, for subscription and close on Tuesday, December 26, 2023. Investors can bid for a minimum of 33 equity shares and in multiples of 33 equity shares thereafter.
Outsourcing Pharma
DECEMBER 18, 2023
Astellasâ drug fezolinetant (Veoza) has been approved by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for the prevention of hot flashes during the menopause.
Express Pharma
DECEMBER 18, 2023
Anil Matai, Director General, Organisation of Pharmaceutical Producers of India (OPPI) shares that in 2024, we anticipate a continued partnership between the government and the pharma industry, driving advancements, fostering innovation, and ultimately contributing to a healthier and more resilient society In 2023, the pharma sector witnessed a dynamic landscape marked by robust government initiatives and a renewed industry focus on innovation, collaboration, and R&D.
Expert insights. Personalized for you.
330 
Let's personalize your content